SK179297A3 - Therapeutic agents - Google Patents

Therapeutic agents Download PDF

Info

Publication number
SK179297A3
SK179297A3 SK1792-97A SK179297A SK179297A3 SK 179297 A3 SK179297 A3 SK 179297A3 SK 179297 A SK179297 A SK 179297A SK 179297 A3 SK179297 A3 SK 179297A3
Authority
SK
Slovakia
Prior art keywords
carbon atoms
group
optionally substituted
halogens
formula
Prior art date
Application number
SK1792-97A
Other languages
English (en)
Slovak (sk)
Inventor
Frank Kerrigan
Sharon C Cheetham
Roy V Davies
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of SK179297A3 publication Critical patent/SK179297A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
SK1792-97A 1995-07-01 1996-06-20 Therapeutic agents SK179297A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9513467.2A GB9513467D0 (en) 1995-07-01 1995-07-01 Therapeutic agents
PCT/EP1996/002676 WO1997002269A1 (en) 1995-07-01 1996-06-20 Condensed thiazole derivatives, having 5-ht receptor affinity

Publications (1)

Publication Number Publication Date
SK179297A3 true SK179297A3 (en) 1998-07-08

Family

ID=10777016

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1792-97A SK179297A3 (en) 1995-07-01 1996-06-20 Therapeutic agents

Country Status (30)

Country Link
US (1) US5869492A (de)
EP (1) EP0836606B1 (de)
JP (1) JPH11508568A (de)
KR (1) KR19990028619A (de)
CN (1) CN1064966C (de)
AR (1) AR003963A1 (de)
AT (1) ATE195942T1 (de)
AU (1) AU708789B2 (de)
BG (1) BG63206B1 (de)
BR (1) BR9609525A (de)
CA (1) CA2222725A1 (de)
CO (1) CO4700463A1 (de)
CZ (1) CZ376297A3 (de)
DE (1) DE69610104T2 (de)
DK (1) DK0836606T3 (de)
ES (1) ES2151175T3 (de)
GB (1) GB9513467D0 (de)
GR (1) GR3034397T3 (de)
HR (1) HRP960306B1 (de)
HU (1) HUP9901258A3 (de)
IL (1) IL122158A (de)
NO (1) NO310660B1 (de)
NZ (1) NZ312130A (de)
PL (1) PL324337A1 (de)
PT (1) PT836606E (de)
SK (1) SK179297A3 (de)
TR (1) TR199701756T1 (de)
TW (1) TW474939B (de)
WO (1) WO1997002269A1 (de)
ZA (1) ZA965494B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9705428D0 (en) * 1997-03-15 1997-04-30 Knoll Ag Therapeutic agents
ATE298747T1 (de) 1998-03-31 2005-07-15 Shionogi & Co Verfahren zur herstellung von 5- hydroxybenzo(b)thiophen-3-carbonsäure
DE19908536A1 (de) 1999-02-26 2000-08-31 Aventis Pharma Gmbh Polycyclische Thiazol-2-yliden Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
GB9911863D0 (en) * 1999-05-21 1999-07-21 Knoll Ag Therapeutic agents
GB9911881D0 (en) * 1999-05-21 1999-07-21 Knoll Ag Therapeutic agents
GB0005789D0 (en) 2000-03-11 2000-05-03 Knoll Ag Therapeutic agents
GB0023610D0 (en) * 2000-09-27 2000-11-08 Knoll Ag Therapeutic agents
DE10112197A1 (de) * 2001-03-14 2002-09-19 Gruenenthal Gmbh Substituierte Pyrazolo- und Thiazolopyrimidine
US8106074B2 (en) 2001-07-13 2012-01-31 Pierre Fabre Medicament Pyridin-2-yl-methylamine derivatives for treating opiate dependence

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0002400A1 (de) * 1977-11-24 1979-06-13 Synthelabo Thiazolderivate, ihre Herstellung, Zwischenprodukte und ihre Verwendung in der Therapie
AU669196B2 (en) * 1992-07-13 1996-05-30 Janssen Pharmaceutica N.V. Novel 4-(3-benzofuranyl)piperidinyl and 4-(3-benzothienyl)piperidinyl derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
IL122158A0 (en) 1998-04-05
WO1997002269A1 (en) 1997-01-23
GR3034397T3 (en) 2000-12-29
NO976157L (no) 1997-12-30
HRP960306A2 (en) 1998-04-30
IL122158A (en) 2000-01-31
DE69610104D1 (de) 2000-10-05
BG63206B1 (bg) 2001-06-29
ZA965494B (en) 1997-12-29
NO310660B1 (no) 2001-08-06
EP0836606B1 (de) 2000-08-30
CZ376297A3 (cs) 1998-06-17
MX9709509A (es) 1998-03-29
CO4700463A1 (es) 1998-12-29
EP0836606A1 (de) 1998-04-22
PL324337A1 (en) 1998-05-25
AR003963A1 (es) 1998-09-30
ATE195942T1 (de) 2000-09-15
TW474939B (en) 2002-02-01
AU708789B2 (en) 1999-08-12
HUP9901258A3 (en) 2000-08-28
CN1064966C (zh) 2001-04-25
HUP9901258A2 (hu) 1999-08-30
GB9513467D0 (en) 1995-09-06
BG102084A (en) 1998-08-31
ES2151175T3 (es) 2000-12-16
US5869492A (en) 1999-02-09
PT836606E (pt) 2001-02-28
JPH11508568A (ja) 1999-07-27
DK0836606T3 (da) 2000-11-20
BR9609525A (pt) 1999-02-23
DE69610104T2 (de) 2001-01-18
NZ312130A (en) 1999-08-30
TR199701756T1 (xx) 1998-04-21
NO976157D0 (no) 1997-12-30
CN1189834A (zh) 1998-08-05
AU6358996A (en) 1997-02-05
CA2222725A1 (en) 1997-01-23
KR19990028619A (ko) 1999-04-15
HRP960306B1 (en) 2001-08-31

Similar Documents

Publication Publication Date Title
EP0295656B1 (de) Benzthiazol-Derivate, ihre Anwendung und pharmazeutische Zusammensetzungen, die sie enthalten
US6187802B1 (en) Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use
SK16852001A3 (sk) Tiazolové deriváty a farmaceutické kompozície ich obsahujúce
SA98190402B1 (ar) تركيب متعدد الشكل البللوري لمضاد مستقبل التاكيكين
CZ289573B6 (cs) Sacharinové deriváty, farmaceutický prostředek obsahující tyto deriváty a pouľití těchto sacharinových derivátů
US6900216B2 (en) Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-A]pyrimidines as antidepressant agents
HU201553B (en) Process for producing tetrahydrofuro- and -thieno(2,3-c)pyridines and pharmaceutical compositions comprising same
FR2598709A1 (fr) Derives de l'acide quinoleinecarboxylique
JP2003500409A (ja) 抗抑鬱剤としての置換イミダゾチアゾール類
SK179297A3 (en) Therapeutic agents
JPH04234860A (ja) チアジン（又はオキサジン）誘導体、その製法及びその合成中間体
EP2513118B1 (de) Bicyclische Thiazole als allosterische Modulatoren der mGluR5-Rezeptoren
WO2002026747A1 (en) Dihydroimidazo[2,1-b]thiazole and dihydro-5h-thiazolo[3,2-a]pyrimidine derivatives with 5-ht receptor affinity
EP0411912B1 (de) Cumarinderivate, ihre Herstellung und ihre Verwendung zur Behandlung von zerebrovaskulären Störungen
US20060094764A1 (en) Cyanothiophenes, their preparation and their use in pharmaceutical compositions
MXPA97009509A (en) Therapeutic agents
GB1569238A (en) 2,5-dihdro-1,2-thiazino(5,6-b)indol-3-carboxamide-1,1-dioxide derivatives
HU194863B (en) Process for producing 5-amino-1,2-dithiol-3-one derivatives and pharmaceutical compositions containing them
JPH05148250A (ja) オキサジアジン誘導体を有効成分として含有する抗血栓剤
HU204256B (en) Process for producing quinoline-2,5-dions and pharmaceutical compositions containing them
CZ9903260A3 (cs) Terapeutická činidla
IL96467A (en) Xahydro-H 1 -Quino-] EF- [1,4] -4,3,2 -Benzoxacspins and related compounds, method and intermediates for their preparation and use as drugs
MXPA99005997A (en) Sulfonamide compounds having 5-ht receptor activity